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Edited by Stuart FergusonAbstract The pur6 gene of the puromycin biosynthetic gene
(pur) cluster from Streptomyces alboniger is shown to be
essential for puromycin biosynthesis. Cell lysates from this
mycelial bacterium were active in linking L-tyrosine to both 30-
amino-30-deoxyadenosine and N6,N6-dimethyl-30-amino-30-deox-
yadenosine with a peptide-like bond. Identical reactions were
performed by cell lysates from Streptomyces lividans or Esch-
erichia coli transformants that expressed pur6 from a variety of
plasmid constructs. Physicochemical and biochemical analyses
suggested that their products were tridemethyl puromycin and O-
demethylpuromycin, respectively. Therefore, it appears that
Pur6 is the tyrosinyl-aminonucleoside synthetase of the puro-
mycin biosynthetic pathway.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Puromycin is an aminonucleoside antibiotic, which is pro-
duced by Streptomyces alboniger (for a review, see [1]). Its
biosynthetic pathway in this mycelial bacterium has been the
subject of a variety of studies [2–8]. The puromycin biosyn-
thetic gene (pur) cluster is within a 13.5-kb DNA fragment that
has been successfully expressed in the heterologous hosts
Streptomyces lividans and Streptomyces griseofuscus [9]. It
contains 10 open reading frames of which those involved in
puromycin biosynthesis appear to be transcribed in a single
polycistronic mRNA [9]. Of these, the products of napH, pur7,
pur10, pac, dmpM and pur8 have been well or partially char-* Corresponding author. Fax: +34-91-4978087.
E-mail address: mfernandez@cbm.uam.es (M.F. Lobato).
1 Present address: Lawrence Berkeley National Laboratory, Life
Sciences Division, 1 Cyclotron Road, ms 84-171, Berkeley, CA
94720, USA.
2 Present address: Centro de Investigacion en Sanidad Animal (CISA-
INIA), Carretera de Algete, Valdeolmos, 28130 Madrid, Spain.
Abbreviations: dA, deoxyadenosine; ODMP, O-demethylpuromycin;
Pac, puromycin N-acetyltransferase; puromycin aminonucleoside,
N6,N6-dimethyl-30-amino-30-deoxyadenosine; ORF, open reading
frame; TDMP, tridemethylpuromycin
0014-5793/$22.00  2004 Published by Elsevier B.V. on behalf of the Feder
doi:10.1016/j.febslet.2004.09.087acterized [3–8]. Sequence comparisons suggested speciﬁc
functions for the products of the remaining genes (pur3, 4, 5
and 6) [8]. Thus, Pur3 would be a phosphatase, Pur4 a putative
aminotransferase, Pur5 a N-methyltransferase and Pur6 a ty-
rosinyl-nucleoside synthetase. These ﬁndings allowed proposal
of a puromycin biosynthetic pathway with ATP as a substrate
[10], which was later slightly modiﬁed [7]. ATP would be de-
hydrogenated by Pur10 (an NAD-dependent ATP dehydro-
genase) to produce 30-keto-30-dehydroATP [8], which would
generate 30-amino-30-dATP by the action of Pur4. This latter
compound, which is a strong inhibitor of DNA-dependent
RNA polymerases [11], is inactivated by Pur7, a nudix pyro-
phosphohydrolase, to produce 30-amino-30-dAMP [7]. At this
stage, dephosphorylation at 50 takes place by the action of the
monophosphatase Pur3 (P. Barrado et al., unpublished re-
sults). The –COOH group of tyrosine would be then linked to
30-amino-30-dA by Pur6 ([10] and this work). It was proposed
that tridemethylpuromycin (TDMP) would be N-acetylated by
the puromycin N-acetyltransferase (Pac) enzyme, an N-ace-
tyltransferase [5], to produce N-acetyl-TDMP. This interme-
diate would be dimethylated at N6 by a N-methyltransferase
(very likely Pur5) and then O-methylated by DmpM, an
ODMP (O-demethylpuromycin)-O-methyltransferase [3,5,10].
This would yield the last precursor, the biologically inactive N-
acetylpuromycin, which appears to be secreted and then hy-
drolyzed by NapH to produce the active antibiotic [7].
The putative tyrosinyl-nucleoside synthetase reaction cata-
lyzed by Pur6 would be ATP-dependent. If so, one would
expect certain similarities of Pur6 with non-ribosomal peptide
synthetases or aminoacyl-tRNA synthetases; however, these
were not found [10]. Its putative activity was suggested by
elimination. An activity of these characteristics would be re-
quired in the biosynthetic pathway of puromycin and no other
gene product from pur was a likely candidate, since either their
functions were known or they were highly similar to proteins
with diﬀerent functions [10]. This work shows that indeed pur6
is an essential gene of the pur cluster and suggests that it en-
codes a tyrosinyl-nucleoside synthetase, which would produce
an intermediate containing the puromycin carbon backbone.2. Materials and methods
2.1. Strains, media, plasmids, DNA methodology and chemicals
Streptomyces alboniger ATCC12461 [12], S. lividans 66 (1326) [13]
and the E. coli DH5a [14] or BL21(DE3)pLysE [15] were previouslyation of European Biochemical Societies.
Fig. 1. Pur6 assays with cell lysates from S. lividans. Assays were
carried out in the presence of L-[14C]tyrosine, the indicated substrates
(all at 1 mM) and S. lividans (pSEXP6.2 or pIJ702) lysates. TLC was
performed with system 1. Lanes 1–2, no substrate. Lanes 3–5, 30-
amino-30-dA. Lanes 6–8, puromycin aminonucleoside. Lanes 9–10,
adenosine. O, origin of the TLC. + and ) indicate presence or absence
of Pur6 and/or ATP.
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[16], pIJ6021 [17] and pGM9 [18] and those from E. coli were pBlue-
script SK()) (Stratagene), pRSETb [19] and pJOE2775 [20]. Plasmid
pFV5 is a pIJ702 derivative containing the pac gene from pur [21].
Streptomyces was grown in solid medium R5 [13], and YEME, con-
taining 5 mM MgSO4, and S media for liquid cultures [9]. When re-
quired, thiostrepton (10 lg/ml), hygromycin B (200 lg/ml), neomycin
B (13 lg/ml), kanamycin (50 lg/ml), ampicillin (100 lg/ml), or chlor-
amphenicol (34 lg/ml) was added at the indicated ﬁnal concentration.
DNA methodology was applied as described [22].
Puromycin aminonucleoside and puromycin were obtained from
Sigma. 30-Amino-30-dATP, L-[U-14C]tyrosine (448 mCi/mmol) and
[3H]acetyl-CoA (5.2 Ci/mmol) were from Amersham. 30-Amino-30-dA
was obtained from Helminthosporium sp. [23]. ODMP and acetyl-
ODMP were chemically synthesized [5]. 30-Amino-30-dAMP was
obtained as described [24]. 50-P-puromycin aminonucleoside was ob-
tained by chemical phosphorylation (TriLink BioTechnologies, San
Diego, CA).
2.2. Preparation of a pur6 deletion mutant
From a NruI–EcoRI fragment of pur (nucleotides 2933–6314) [10],
an AccI–StyI internal fragment (nucleotides 333–1687) of the pur6
coding sequence (58%) [10] was replaced by a hyg gene, which con-
tained the promoter and coding sequence and lacked the transcription
terminator signal. The resulting fragment was inserted in the XhoI–
XbaI thermosensitive replicon fragment of pGM9. The resulting
pSDP6.2 was transformed into S. alboniger [18]. Neomycin B-sensitive,
hygromycin B-resistant colonies were selected. Southern blot analyses
permitted to characterize several correct mutants (data not shown).
2.3. Expression of Pur6 in Streptomyces
To express Pur6 in S. lividans, a 2.7-kb NotI–BglII fragment (nu-
cleotides 3524–6204) [10] from pur, which contained an intact pur6
gene, was inserted in the BglII replicon fragment of pIJ702. One of the
resulting construct (pSEXP6.2), which contained pur6 in the same
orientation than the mel promoter of pIJ702, was isolated upon
transformation into S. lividans. In addition, pur6 was included under
the thiostrepton-inducible tipA promoter of pIJ6021 resulting in con-
struct pSEXP6.3.
To prepare cell lysates, S. alboniger and S. lividans strains were
grown in S and YEME medium, respectively. Antibiotics were added
as required. Cell mycelia from 12 ml cultures were resuspended in 0.5
ml of 300 mM NaCl, 50 mM KH2PO4, pH 8.0, and sonicated 3 times
for 10 s at 15 micron at 4 C. Lysates were spun at 15 000 g for 10
min and the resulting supernatants were used immediately or main-
tained at )70 C. Proteins were analyzed by SDS–PAGE [22].
2.4. Enzymatic assays
Unless otherwise indicated, a Pur6 assay (20 ll), as deduced from an
optimization process, contained 1 mM MgCl2, 1 mM ATP, 1 mM of
the diﬀerent substrates assayed, 0.1 mM L-[U-14C]tyrosine (50 mCi/
mmol), 50 mM Tris–HCl, pH 8.8, and 8–35 lg protein (the optimal
one for the relevant lysate) from either Streptomyces or E. coli lysates.
Unless otherwise indicated, reactions were incubated for 30 min at 30
C and then stopped by heating at 85 C for 5 min. These were found
to be the optimal conditions. Samples (0.5 ll) were analyzed using
TLC in four diﬀerent systems. Systems 1 and 2: PEI-Cellulose F
(Merck) and 1 M LiCl or 0.1 M ammonium acetate, acetonitrile (1:2),
respectively. Systems 3 and 4: cellulose F (Merck) and 0.1 M ammo-
nium acetate, acetonitrile (80:20) or 1-butanol, acetic acid, water
(12:3:5), respectively. Dried sheets were exposed for 5–15 h on a Fuji
Bas Imaging plate MP2040S and analyzed by Fujiﬁlm BAS-1500.
Analysis and quantiﬁcation were performed with the aid of TINA 2.0
program. Protein was quantiﬁed with the Bio-Rad assay kit.
For sequential Pur6 and Pac assays, Pur6 reactions were carried out
in the presence of S. lividans (pSEXP6.2 or pSEXP6.3) lysates and L-
[14C]tyrosine and then inactivated by heating at 85 C for 5 min. They
were then made up 10% glycerol (v/v), 2 mM EDTA (to complex Mg2þ
ions), 0.2 mM acetyl-CoA and 50 mM Tris–HCl, pH 8.5. 10 ll of a S.
lividans (pIJ702) or S. lividans (pFV5) [21] lysate was then added to a
ﬁnal volume of 50 ll. Reactions were incubated at 30 C for 30 min
and analyzed by TLC as referred. When Pur6 reactions were per-
formed with unlabeled 0.1 mM L-tyrosine, assays were performed as
referred except that 1.6 nM [3H]acetyl-CoA was used. Puromycin was
quantiﬁed in culture ﬁltrates by the Pac assay [5].2.5. Expression of Pur6 in E. coli
A 2.4-kb MseI–BglII (3768-6204) [10], which contains the complete
pur6 sequence except its three initial codons, was blunt-ended with the
Klenow enzyme and inserted in the PvuII replicon fragment of the
IPTG- and the rhamnose-inducible expression vectors pRSETb and
pJOE2775, respectively. The last plasmid was expressed in E. coli
JM109. Expression and attempts of puriﬁcation of Pur6 were carried
out as described [15,19].3. Results and discussion
3.1. Pur6 activity in diﬀerent cell extracts
Putatively, Pur6 should catalyze a peptide-like amide bond
between the –COOH group of tyrosine and the 30-amino
group of 30-amino-30-dA or a close intermediate [10]. This
reaction would require an activation of tyrosine, which could
be achieved by means of ATP and perhaps a divalent cation.
Therefore, Pur6 activity was initially assayed in a cell lysate
from S. lividans (pSEXP6.2), in the presence of either 30-
amino-30dA, puromycin aminonucleoside, or adenosine. The
results showed the modiﬁcation of the ﬁrst and second sub-
strate, but not of the third one. These reactions were ATP-
and Mg2þ-dependent (Fig. 1 and data not shown). The
product of the reaction in the presence of 30-amino-30-dA was
thought to be TDMP, whereas that with puromycin amino-
nucleoside had identical Rf to synthetic ODMP in four dif-
ferent TLC systems (Table 1), therefore suggesting that this
was the reaction product. The reaction was linear for the
initial 5 min. After 25–30 min of incubation, a plateau was
reached. The ﬁnal yield of the product was lower than 5% of
the initial L-[14C]tyrosine present in the reaction (data not
shown). Since 30-amino-30-dAMP and 50-P-puromycin am-
inonucleoside were not substrates of Pur6, they most likely
did not appear as biosynthetic intermediates, which clariﬁes
earlier speculations [10]. Neither cordycepin (30-deoxyadeno-
sine) nor the aminonucleoside antibiotic A201A that contains
the 30-amino-30-dA moiety of puromycin were substrates of
Pur6 (data not shown).
Pur6 activity and puromycin production were assayed in
samples taken at diﬀerent times during the growth curve of a
variety of Streptomyces strains. In S. alboniger, both puro-
mycin and Pur6 activity were initially detected at the middle of
the log phase and reached a maximum at 50–60 h of growth
Fig. 3. Electrophoretic analysis of cell lysates. Cell lysates of S. lividans
transformed with pIJ702 (1), pSEXP6.2 (2), pIJ6021 (3) or pSEXP6.3
(4) were subjected to SDS–PAGE (7%) and stained with Coomasie
Blue. The positions of molecular mass markers are indicated at the left.
Table 1
Rf values of several compounds in four TLC systems
Compound TLC Systems
1 2 3 4
30-Amino-30-dAa 0.36 0.44 0.53 0.35
Puromycin aminonucleosidea 0.47 0.81 0.72 0.51
L-Tyrosineb 0.63 0.48 0.73 0.39
ATPa 0.28 0.06 0.93 0.10
ADPa 0.56 0.16 0.90 0.13
AMPa 0.67 0.49 0.97 0.20
TDMPb ;c 0.27 0.67 0.54 0.39
ODMPa ;b ;d ;e 0.37 0.88 0.73 0.63
N-Acetyl TDMPb ; f 0.38 0.86 0.63 0.72
N-Acetyl ODMPa ;b ;e ;f 0.52 0.96 0.77 0.93
Puromycina 0.66 0.96 0.75 0.78
Acetyl CoAb 0.93 0.78 0.98 0.61
N-Acetyl puromycinb ;e 0.54 1 0.81 0.94
aDetected with UV light at 254 nm.
bDetected as a radioactive product.
c Product of a Pur6 reaction with L-[14C]tyrosine and 30-amino-30-dA
as substrates.
d Product of a Pur6 reaction with L-[14C]tyrosine and puromycin am-
inonucleoside as substrates.
e Chemically synthesized.
f As 3 and 4 but N-acetylated with Pac.
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Dpur6 (pIJ702) lysates, whereas it was reinstated in a time-
dependent manner in S. alboniger Dpur6 (pSEXP6.2). Similar
results were obtained with lysates from a thiostrepton-induced
S. lividans (pSEXP6.3), which abundantly expressed a protein
of a size similar to that of Pur6 (84 kDa) (Fig. 3). However, all
attempts to purify Pur6 from the diﬀerent Streptomyces strains
that expressed it were unsuccessful. Apparently, the activity
was destroyed by ultracentrifugation on glycerol gradients or
by DEAE-cellulose or DEAE-Sepharose CL-6B column
chromatography. It only supported a ﬁltration cycle through a
PD-10 Sephadex G-25 column. Nevertheless, this preparation
lost its activity after 24 h at 4 C or by a cycle of freezing and
thawing (data not shown). These results suggested that under
the conditions used, Pur6 was highly labile. Further puriﬁca-
tion attempts were carried out in E. coli by adding a six His
tale to Pur6 in the expression vectors pRSETb and pJOE2775.
Most of the expressed fusion Pur6 protein formed inclusion
bodies, a phenomenon that was not alleviated by varyingFig. 2. Expression of Pur6 in diﬀerent strains. Culture ﬁltrates were
obtained at the indicated times from S. alboniger () and S. alboniger
Dpur6 transformed with either pIJ702 (s) or pSEXP6.2 (n). At the
indicated times puromycin ( – ) was quantiﬁed by the Pac assay. Cell
lysates were obtained and their Pur6 activity (  ) was assayed in the
presence of 30-amino-30-dA. OD660(- - -).culture conditions or using diﬀerent E. coli strains (data not
shown). Although the minimal amount of soluble Pur6 that
accumulated in the crude lysates permitted to detect clearly its
activity, further puriﬁcation attempts through Ni–NTA col-
umns failed to recover active enzyme.
3.2. The pur6 gene is essential for puromycin biosynthesis
Six S. alboniger Dpur6 mutants were obtained (see Section
2). None of them produced puromycin (Fig. 2 and data not
shown). Therefore, these ﬁndings indicate that pur6 is an es-
sential gene of the pur cluster. Construct pSEXP6.2, which
carries pur6, was introduced in several S. alboniger Dpur6
mutants. In all cases, pSEXP6.2 rescued puromycin biosyn-
thesis (an example is presented in Fig. 2), which conﬁrms that
pur6 is essential for puromycin production in S. alboniger.
3.3. Characterization of the Pur6 reaction products
The Pac enzyme of the puromycin biosynthetic pathway N-
acetylates puromycin, and its product, N-acetylpuromycin, is
biologically inactive. Pac is a highly speciﬁc enzyme, which
only recognizes compounds with the puromycin carbon
backbone like ODMP and chriscandin [5]. Therefore, it should
be expected that the products of Pur6 reactions with either 30-
amino-30-dA or puromycin aminonucleoside (the putative
TDMP and ODMP, respectively) were N-acetylated by Pac.
To examine this possibility, two diﬀerent assays were per-
formed. In the ﬁrst one, Pur6 reactions were carried out with
L-[14C]tyrosine and either 30-amino-30-dA or puromycin am-
inonucleoside. Then their products were reacted, in the pres-
ence of unlabeled acetyl-coenzyme A, with Pac. In the second
one, Pur6 reactions were carried out with unlabeled L-tyrosine,
whereas Pac reactions were performed with [3H]acetyl-CoA. In
both cases, novel radioactive products with similar Rf ap-
peared, which were absent in the control reactions lacking
Pur6 or Pac (Fig. 4). In addition, the spots identiﬁed as N-
acetyl-ODMP had similar Rf than synthetic N-acetyl-ODMP
in the four TLC systems (Table 1). These ﬁndings suggest that
the products synthesized in Pur6 reactions are N-acetylated by
Pac. Given the high speciﬁcity of this enzyme and the mobility
Fig. 4. Sequential Pur6 and Pac assays. Pur6 reactions were performed with either 30-amino-30-dA (A) or puromycin aminonucleoside (B). TLC was
performed with system 2. Rf s are given in Table 1. Lanes 1–4, Pur6 and Pac reactions were performed in the presence of L-[
14C]tyrosine and un-
labeled acetyl-CoA, respectively. Lanes 6–9, Pur6 and Pac reactions were performed with unlabeled L-tyrosine and [3H]acetyl-CoA, respectively. An
equal mixture of samples from reactions 4 and 6 was spotted on line 5. + and ) indicate presence or absence of Pur6 and/or Pac, respectively. O,
origin of the TLC. Cell lysates were from S. lividans (pSEXP6.3).
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Pur6 catalyzes the incorporation of L-tyrosine on both 30-
amino-30-dA and puromycin aminonucleoside producing
TDMP or ODMP, respectively (Fig. 5). Furthermore, TDMP
was detected in samples of puromycin, which suggested that
this compound is an intermediate of the pathway. This
suggestion was reinforced by the presence of N6,O-didemethyl-
puromycin and ODMP, the putative consecutive intermedi-
ates, in the analyzed puromycin samples [4]. Although Pur6
catalyzes both reactions with apparently similar kinetics (data
not shown), the experimental conditions used in this work did
not permit to determine the Km values for both substrates,Fig. 5. Schematic view of possible reactions catalyzed by Pur6.which could helped to identify the correct reaction in the pu-
romycin biochemical pathway [5]. The mechanism of the re-
action catalyzed by Pur6 would be reminiscent of that used by
the non-ribosomal peptide synthetases. Thus, the Pur6 reac-
tion requires ATP and Mg2þ ions, as it is the general case with
peptide synthetases. However, from an evolutionary point of
view, Pur6 does not present clear similarities with members of
this protein family. Indeed, it lacks all their conserved domain
and it does not present similarities to other proteins, including
aminoacyl-tRNA synthetases. In fact, its novel catalyzed re-
action is quite separate from those catalyzed by these groups of
proteins, which could help to explain their dissimilarity. In any
case, by similarity with these synthetases, the fate of the ATP
during reaction might be AMP+PPi. However, there was no
indication on this possibility on the TLC plates nor further
work on this subject was performed. There are other known
natural aminonucleoside antibiotics produced by fungi (ho-
mocitrullylaminoadenosine, lisylaminoadenosine and chri-
scandine) that contain a 30-amido linkage similar to that of
puromycin. Presumably, they contain enzymes similar to Pur6,
although they have not yet been identiﬁed.
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